Blister Packaging

RSS

The pharmaceutical industry is focused on the rollout of the Drug Quality and Security Act (DQSA) and improving the “safety of the supply chain”. Unfortunately, the problems surrounding opioid abuse happen in or after pharmacy.

Packaging innovation protects solid dose pharmaceuticals from moisture, oxygen and odors while enhancing shelf life, eliminating purging/secondary packaging and enabling a move from bottles to blisters.

Packaging in the healthcare market is a growing industry with many challenges to overcome and exciting opportunities to be had.

Bilcare Research Inc., a division of one of the world’s largest manufacturers of blister packaging solutions, announces an investment into a new laminator at its Wilmington, DE facility. 

One of the world’s largest manufacturers of blister packaging solutions, has hired Anna Frolova-Levi as vice president of sales & marketing

World demand to rise 6.5% annually through 2019 

The use of blister packaging in the pharmaceutical industry continues to rise.

Lately, the phrase pharmaceutical safety conjures up images of 2D bar codes, discussions of serialization and pedigree, 10 years of rolling implementation of the Federal Drug Quality and Security Act (DQSA) but pharmaceutical safety means something much more basic and, sadly, long overlooked.